Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TANC1 is a large scaffold protein prominently expressed in the adult brain, particularly in postsynaptic densities where it organizes synaptic complexes, influencing dendritic spine maintenance and the strength/plasticity of excitatory synapses[1][2][5]. It contains tetratricopeptide repeat, ankyrin repeat, and coiled-coil domains, facilitating protein-protein interactions and possibly regulating key neuronal signaling pathways, including those of the glutamate receptor, planar cell polarity, and Hippo signaling[1][2]. Functional and genetic studies suggest TANC1 is important in neurodevelopment and synaptic structure, with mutations and disruption implicated in intellectual disability and autism spectrum disorder[1][2][4]. While TANC1 is not a direct drug target, understanding its scaffolding role in neuronal architecture is valuable for elucidating the molecular basis of several neurodevelopmental conditions[1][2][5].
Null (no drugs are known to target TANC1 directly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1 (TANC1).